Hospices Civils de Lyon - Hôpital Neurologique Pierre Wertheimer - Service de Médecine Physique et Réadaptation
Lyon, 69500, France
NCT Number: NCT02742506
Exposure to music improves cognitive function in 'healthy' participants and in brain-damaged patients. However, it is still difficult to understand what precisely in music causes a positive effect : are they emotional components, familiarity or preference which improve cognition or is there any specific effect of music? Moreover, it is not yet possible to characterize the neural and functional links between the brain systems solicited by music and those associated with other cognitive functions enhanced by music.
Finally, researches on brain-damaged patients have not exploited the potential effect of music on the level of alert and perceptual awareness, while this type of stimulation could be a valuable tool to improve cognition in patients with a disturbance of consciousness and alertness.
The main objective is to describe the impact of music on the brain's response to self-referential or neutral stimuli in brain-damaged patients with persistent consciousness disorder after a coma and in healthy participants.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Interventional
Not applicable
Lyon, 69500, France
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Brain-damaged patients :
Inclusion criteria
Exclusion criteria
Healthy participants :
Inclusion criteria
Exclusion criteria
EEG will be performed to assess brain activity in response to sounds of different nature, including music and the given name of the registered person
Time frame: 24 hours after inclusion
Improvement of the P300 response (increase in amplitude and / or a decrease in latency) to the first name pronunciation will be assessed in patients in coma, in a vegetative state or in a minimally conscious state, when it is preceded by a favorite or familiar sound (music, language, environmental noise) and / or a positive emotional connotation, compared to a control condition (unfamiliar sound and / or neutral emotional connotation). This improvement in brain response will be the sign of a more efficient categorization of patient's own name.
Time frame: 24 hours after inclusion
Improvement of the P300 response (increase in amplitude and / or a decrease in latency) to a self-referential stimulation (eg first name pronunciation) compared to a non-self-referential stimulation (eg other name) will be assessed in healthy participants when it is preceded by a favorite or familiar sound (music, language, environmental noise) and / or a positive emotional connotation, compared to a control condition (sound unfamiliar and / or neutral emotional connotation)
Time frame: 24 hours after inclusion
Increase of the P300 response (increase in amplitude and / or a decrease in latency) to a self-referential stimulation (e.g. name pronunciation) will be assessed when the patient is awake (according to EEG measures and / or eye opening) compared to when the patient is asleep (according to EEG measures and / or eye closure).
Time frame: 24 hours after inclusion
Increase of the level of activity measured in the medial prefrontal cortex will be assessed in healthy participants after a favorite or familiar sound (music, language, environmental noise) and / or a positive emotional connotation, compared to a control condition (unfamiliar sound and / or neutral emotional connotation).
Hospices Civils de Lyon
Other
Acronym: MUSICOREVEIL
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07485361
Brain Damage, Chronic, Brain Diseases
Los Angeles, California, United States
View Trial DetailsNCT01620957
Brain Damage, Chronic, Brain Diseases
Toulouse, Haute Garonne, France
View Trial DetailsNCT03504709
Brain Diseases, Brain Injuries
Boston, Massachusetts, United States
View Trial DetailsNCT04476589
COVID-19, Coma
Boston, Massachusetts, United States
View Trial Details